Skip to main content

Table 1 Demographic characteristics of patients with hematological malignances

From: A comparison of measurement properties between EORTC QLU-C10D and FACT-8D in patients with hematological malignances

Variable

Baseline (N = 308)

3–4 Months Follow-up

Yes (N = 131)

No (N = 177)

p-value

Gender

    

 Male

144 (46.8%)

55 (42.0%)

89 (50.3%)

 

 Female

164 (53.2%)

76 (58.0%)

88 (49.7%)

0.166

Age

    

 ≤ 29

25 (8.1%)

10 (7.6%)

15 (8.5%)

 

 30–39

41 (13.3%)

19 (14.6%)

22 (12.4%)

 

 40–49

55 (17.9%)

24 (18.3%)

31 (17.5%)

0.943

 ≥ 50

187 (60.7%)

78 (59.5%)

109 (61.6%)

 

Registered residence

    

 City

144 (46.8%)

55 (42.0%)

89 (50.3%)

 

 Rural

164 (53.2%)

76 (58.0%)

88 (49.7%)

0.166

Marital status

    

 Unmarried

34 (11.0%)

14 (10.7%)

20 (11.3%)

 

 Married

232 (75.4%)

104 (79.4%)

128 (72.3%)

 

 Other

42 (13.6%)

13 (9.9%)

29 (16.4%)

0.243

Employment status

    

 Employed

187 (60.7%)

81 (61.8%)

106 (59.9%)

 

 Repaired

76 (24.7%)

30 (22.9%)

46 (26.0%)

 

 Unemployed

45 (14.6%)

20 (15.3%)

25 (14.1%)

0.817

Frequency of health check-ups

    

 Regularly

111 (36.0%)

43 (32.8%)

68(38.4%)

 

 Occasionally

113 (36.7%)

49 (37.4%)

64 (36.2%)

 

 Hardly ever

84 (27.3%)

39 (29.8%)

45 (25.4%)

0.547

Family care

    

 Yes

285 (92.5%)

122 (93.1%)

163 (92.1%)

 

 No

23 (7.5%)

9 (6.9%)

14 (7.9%)

0.828

Economic pressure

    

 No

22 (7.1%)

8 (6.2%)

14 (7.9%)

 

 Mild

58 (18.8%)

24 (18.3%)

34 (19.2%)

 

 Moderate

112 (36.4%)

51 (38.9%)

61 (34.5%)

 

 Severe

116 (37.7%)

48 (36.6%)

68 (38.4%)

0.837

Disease type

    

 Lymphoma

171 (55.5%)

68 (51.9%)

103 (58.2%)

 

 Leukemia

75 (24.4%)

35 (26.7%)

40 (22.6%)

 

 Myeloma

62 (20.1%)

28 (21.4%)

34 (19.2%)

0.539

Mean response time (months)

 

3.9

 Â